Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 428

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 1A
Chunk 428
---
 may increase
substantially in the future in connection with new research and development initiatives and continued product commercialization efforts.
We may need to raise additional capital to fund our operations, continue to conduct clinical trials to support potential regulatory approval
of marketing applications and to fund commercialization of our products.

28

The
amount and timing of our future funding requirements will depend on many factors, including, but not limited to:

    ●
    the
    timing of FDA approval, if any, and approvals in international markets of our product candidates, if at all; 

    ●
    the
    timing and amount of revenue from sales of our products, or revenue from grants or other sources;

    ●
    The
    rate of progress and cost of our clinical trials and other product development programs; 

    ●
    costs
    of establishing or outsourcing sales, marketing, and distribution capabilities; 

    ●
    costs
    and timing of completion of expanded in-house manufacturing facilities as well as any outsourced commercial manufacturing supply
    arrangements for our product candidates; 

    ●
    costs
    of filing, prosecuting, defending, and enforcing any patent claims and other intellectual property rights associated with our product
    candidates; 

    ●
    the
    effect of competing technological and market developments; 

    ●
    personnel,
    facilities, and equipment requirements; and 

    ●
    the
    terms and timing of any additional collaborative, licensing, co-promotion, or other arrangements that we may establish.

While
we expect to fund our future capital requirements from several sources including existing cash balances, future cash flows from operations
and the proceeds from equity offerings, we cannot assure you that any of these funding sources will be available to us on favorable terms,
or at all. Further, even if we can raise funds from all of the above sources, the amounts raised may not be sufficient to meet our future
capital requirements.

Operating
results may vary significantly in future periods.

Our
expenses and operating results have fluctuated in the past and our revenues, expenses, and operating results are likely to fluctuate
significantly in the future. Our financial results are unpredictable and may fluctuate, for among other reasons, due to:

    ●
    commercial
    sales of our products;

    ●
    our
    achievement of product development objectives and milestones;

    ●
    clinical
    trial enrollment and expenses;

    ●
    research
    and development expenses; and

    ●